A survey of over 400 patients in the U.S. between 18 and 65 years old with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) uncovered insights about conversation gaps with their rheumatologist and their care experience.
The U.S.-based survey was conducted between October 23, 2023 – January 2, 2024, and responses were obtained from 464 patients who self-reported having been diagnosed with moderate to severe RA, PsA, or axSpA.
A survey of over 400 patients in the U.S. between 18 and 65 years old with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) uncovered insights about conversation gaps with their rheumatologist and their care experience.
The U.S.-based survey was conducted between October 23, 2023 – January 2, 2024, and responses were obtained from 464 patients who self-reported having been diagnosed with moderate to severe RA, PsA, or axSpA.
47% of patients said they describe their pain differently to family and friends than they do to their rheumatologist.
The U.S.-based survey was conducted between October 23, 2023 – January 2, 2024, and responses were obtained from 464 patients who self-reported having been diagnosed with moderate to severe RA, PsA, or axSpA.
47% of patients said they describe their pain differently to family and friends than they do to their rheumatologist.
The U.S.-based survey was conducted between October 23, 2023 – January 2, 2024, and responses were obtained from 464 patients who self-reported having been diagnosed with moderate to severe RA, PsA, or axSpA.
34% of patients said they struggle to describe the challenges they have with their treatment to their rheumatologist.
The U.S.-based survey was conducted between October 23, 2023 – January 2, 2024, and responses were obtained from 464 patients who self-reported having been diagnosed with moderate to severe RA, PsA, or axSpA.
34% of patients said they struggle to describe the challenges they have with their treatment to their rheumatologist.
The U.S.-based survey was conducted between October 23, 2023 – January 2, 2024, and responses were obtained from 464 patients who self-reported having been diagnosed with moderate to severe RA, PsA, or axSpA.
To bridge the conversation gaps, we must join together to break the silence that shrouds the unseen nature of rheumatic diseases.
The U.S.-based survey was conducted between October 23, 2023 – January 2, 2024, and responses were obtained from 464 patients who self-reported having been diagnosed with moderate to severe RA, PsA, or axSpA.
To bridge the conversation gaps, we must join together to break the silence that shrouds the unseen nature of rheumatic diseases.
The U.S.-based survey was conducted between October 23, 2023 – January 2, 2024, and responses were obtained from 464 patients who self-reported having been diagnosed with moderate to severe RA, PsA, or axSpA.
Rheum for Dialogue is an initiative committed to bridging the conversation gaps that exist between patients living with a rheumatic disease and their doctors, so care decisions become joint decisions.
By elevating patient experiences and providing personalized resources, Rheum for Dialogue aims to empower patients to actively own their care and hold meaningful, transparent conversations with their doctors.
Ready to join the conversation?
A Joint Discussion Between a Patient and a Rheumatologist
Cheryl, a patient advocate living with rheumatoid arthritis and founder of Arthritis Life, and Dr. Elizabeth Ortiz, a board-certified rheumatologist and founder of Connected Rheumatology, sat down for a dynamic discussion about creating a space for shared decision-making and tips to advocate for a care plan that works for you.
Arthritis Life is a platform that provides educational and empowering content for people living with inflammatory arthritis, inspiring patients to live their best life with their condition. Connected Rheumatology is a platform that provides patient-focused, up-to-date information about all things rheumatology to help patients make informed health decisions with their doctor.
Hear more from the discussion with Cheryl and Dr. Ortiz
A Resource Hub to Feel Empowered on Your Rheumatic Disease Journey
Patient Survey Insights
Did you know over half of RA, PsA and axSpA patients surveyed by AbbVie reported feeling at least one negative emotion after leaving appointments with their rheumatologist? More survey findings shed light on the importance of working together with your doctor to help overcome these challenges.
This online survey was sponsored by AbbVie and conducted by Oracle Life Sciences. It is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated.
Tools and Resources
Explore condition-specific resources provided by AbbVie and designed to support your care journey and help you feel prepared for conversations with your doctor.
Coming Soon
Stay tuned for access to an online tool that’s designed by doctors and patients to help you identify how you are feeling and receive personalized tips for communicating with your doctor so care decisions are tailored to your needs.
This tool is provided by The Global Healthy Living Foundation and sponsored by AbbVie.
Reference:
1. AbbVie. (2024). 2023 USPA Rheumatology Patient Insights Survey. Data on File.
